Infectious Disease Diagnostics - Global Market Outlook (2018-2027)
According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $15.53 billion in 2018 and is expected to reach $28.79 billion by 2027 growing at a CAGR of 7.1% during the forecast period. Increasing prevalence of infectious diseases, growing R& D activities coupled with the development of novel technologies and rising new diagnostic tests for the control of infectious diseases are the major factors propelling the market growth. However, lack of skilled technicians/professionals and high cost of these devices is hampering the market growth.
Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Any bacteria which cause infectious disease are called pathogens. Diagnosis for the causative organism of bacterial disease is always difficult since infections show symptoms like lethargy and fever.
Based on the technology, DNA sequencing & next-generation sequencing (NGS) segment is going to have a lucrative growth during the forecast period due to factors such as development in sequencing technologies, rising awareness and taking of personalized medicine in which this technology has major applications and growing application of molecular diagnostic technologies in pharmacogenetics and point-of-care testing are expected to boost the growth of this technology in the future. By geography, North America is likely to have a huge demand owing to extremely developed healthcare system, mounting prevalence of infectious diseases, the existence of a huge number of leading national clinical laboratories, and simple accessibility to technologically advanced devices in the region.
Some of the key players profiled in the Infectious Disease Diagnostics Market are Abbott Diagnostic, Alere, Beckman Coulter , Becton, Dickinson and Company (BD), bioMérieux, Bio-Rad Laboratories, Cavidi, Cepheid, Corgenix, Diasorin, Diaxonhit , Eiken Chemical, EMD Millipore, J.Mitra, Meridian Bioscience, Roche Diagnostic , Siemens Healthcare Diagnostics, TECHLAB, Thermo Fisher Scientific and Trinity Biotech.
Product & Services Covered:
• Assays, Kits, & Reagents
• Instruments
• Software
Test Types Covered:
• Biopsies
• Imaging Test
• Laboratory Tests
Technologies Covered:
• Biochemical Characterization
• Clinical Microbiology
• Conventional Techniques
• DNA Microarray
• DNA Sequencing & Next-Generation Sequencing (NGS)
• Hybridization and Microarrays
• Immunodiagnostics
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Microscopy
• Molecular Techniques
• POC infectious disease diagnostics test
• Polymerase Chain Reaction (PCR)
Disease Types Covered:
• Acquired Immunodeficiency Syndrome (AIDS)
• Bacterial Infection
• Cardiovascular infection
• Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
• Coronavirus
• Glandular fever
• Hepatitis
• Hospital-Acquired Infections (HAIS)
• Human Immunodeficiency Virus (HIV)
• Human Papillomavirus (HPV)
• Influenza
• Methicillin-resistant Staphylococcus Aureus (MRSA)
• Tuberculosis (TB)
• Other Disease Types
End Users Covered:
• Academic/Research Institutes
• Ambulatory Surgical Centers
• Blood Banks
• Contract Research Organization
• Diagnostic Clinics
• Home healthcare
• Hospital/Clinical Laboratories
• Nursing Homes
• Physician Offices
• Reference Laboratories
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Infectious Disease Diagnostics Market, By Product & Service
5.1 Introduction
5.2 Assays, Kits, & Reagents
5.3 Instruments
5.4 Software
6 Global Infectious Disease Diagnostics Market, By Test Type
6.1 Introduction
6.2 Biopsies
6.3 Imaging Test
6.4 Laboratory Tests
7 Global Infectious Disease Diagnostics Market, By Technology
7.1 Introduction
7.2 Biochemical Characterization
7.3 Clinical Microbiology
7.4 Conventional Techniques
7.5 DNA Microarray
7.6 DNA Sequencing & Next-Generation Sequencing (NGS)
7.7 Hybridization and Microarrays
7.8 Immunodiagnostics
7.9 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.10 Microscopy
7.11 Molecular Techniques
7.12 POC infectious disease diagnostics test
7.13 Polymerase Chain Reaction (PCR)
8 Global Infectious Disease Diagnostics Market, By Disease Type
8.1 Introduction
8.2 Acquired Immunodeficiency Syndrome (AIDS)
8.3 Bacterial Infection
8.4 Cardiovascular infection
8.5 Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
8.6 Coronavirus
8.7 Glandular fever
8.8 Hepatitis
8.9 Hospital-Acquired Infections (HAIS)
8.10 Human Immunodeficiency Virus (HIV)
8.11 Human Papillomavirus (HPV)
8.12 Influenza
8.13 Methicillin-resistant Staphylococcus Aureus (MRSA)
8.14 Tuberculosis (TB)
8.15 Other Disease Types
9 Global Infectious Disease Diagnostics Market, By End User
9.1 Introduction
9.2 Academic/Research Institutes
9.3 Ambulatory Surgical Centers
9.4 Blood Banks
9.5 Contract Research Organization
9.6 Diagnostic Clinics
9.7 Home healthcare
9.8 Hospital/Clinical Laboratories
9.9 Nursing Homes
9.10 Physician Offices
9.11 Reference Laboratories
10 Global Infectious Disease Diagnostics Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Abbott Diagnostic
12.2 Alere
12.3 Beckman Coulter
12.4 Becton, Dickinson and Company (BD)
12.5 bioMérieux
12.6 Bio-Rad Laboratories
12.7 Cavidi
12.8 Cepheid
12.9 Corgenix
12.10 Diasorin
12.11 Diaxonhit
12.12 Eiken Chemical
12.13 EMD Millipore
12.14 J.Mitra
12.15 Meridian Bioscience
12.16 Roche Diagnostic
12.17 Siemens Healthcare Diagnostics
12.18 TECHLAB
12.19 Thermo Fisher Scientific
12.20 Trinity Biotech
List of Tables
1 Global Infectious Disease Diagnostics Market Outlook, By Region (2017-2027) ($MN)
2 Global Infectious Disease Diagnostics Market Outlook, By Product & Service (2017-2027) ($MN)
3 Global Infectious Disease Diagnostics Market Outlook, By Assays, Kits, & Reagents (2017-2027) ($MN)
4 Global Infectious Disease Diagnostics Market Outlook, By Instruments (2017-2027) ($MN)
5 Global Infectious Disease Diagnostics Market Outlook, By Software (2017-2027) ($MN)
6 Global Infectious Disease Diagnostics Market Outlook, By Test Type (2017-2027) ($MN)
7 Global Infectious Disease Diagnostics Market Outlook, By Biopsies (2017-2027) ($MN)
8 Global Infectious Disease Diagnostics Market Outlook, By Imaging Test (2017-2027) ($MN)
9 Global Infectious Disease Diagnostics Market Outlook, By Laboratory Tests (2017-2027) ($MN)
10 Global Infectious Disease Diagnostics Market Outlook, By Technology (2017-2027) ($MN)
11 Global Infectious Disease Diagnostics Market Outlook, By Biochemical Characterization (2017-2027) ($MN)
12 Global Infectious Disease Diagnostics Market Outlook, By Clinical Microbiology (2017-2027) ($MN)
13 Global Infectious Disease Diagnostics Market Outlook, By Conventional Techniques (2017-2027) ($MN)
14 Global Infectious Disease Diagnostics Market Outlook, By DNA Microarray (2017-2027) ($MN)
15 Global Infectious Disease Diagnostics Market Outlook, By DNA Sequencing & Next-Generation Sequencing (NGS) (2017-2027) ($MN)
16 Global Infectious Disease Diagnostics Market Outlook, By Hybridization and Microarrays (2017-2027) ($MN)
17 Global Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2017-2027) ($MN)
18 Global Infectious Disease Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Technology (INAAT) (2017-2027) ($MN)
19 Global Infectious Disease Diagnostics Market Outlook, By Microscopy (2017-2027) ($MN)
20 Global Infectious Disease Diagnostics Market Outlook, By Molecular Techniques (2017-2027) ($MN)
21 Global Infectious Disease Diagnostics Market Outlook, By POC infectious disease diagnostics test (2017-2027) ($MN)
22 Global Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2017-2027) ($MN)
23 Global Infectious Disease Diagnostics Market Outlook, By Disease Type (2017-2027) ($MN)
24 Global Infectious Disease Diagnostics Market Outlook, By Acquired Immunodeficiency Syndrome (AIDS) (2017-2027) ($MN)
25 Global Infectious Disease Diagnostics Market Outlook, By Bacterial Infection (2017-2027) ($MN)
26 Global Infectious Disease Diagnostics Market Outlook, By Cardiovascular infection (2017-2027) ($MN)
27 Global Infectious Disease Diagnostics Market Outlook, By Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG) (2017-2027) ($MN)
28 Global Infectious Disease Diagnostics Market Outlook, By Coronavirus (2017-2027) ($MN)
29 Global Infectious Disease Diagnostics Market Outlook, By Glandular fever (2017-2027) ($MN)
30 Global Infectious Disease Diagnostics Market Outlook, By Hepatitis (2017-2027) ($MN)
31 Global Infectious Disease Diagnostics Market Outlook, By Hospital-Acquired Infections (HAIS) (2017-2027) ($MN)
32 Global Infectious Disease Diagnostics Market Outlook, By Human Immunodeficiency Virus (HIV) (2017-2027) ($MN)
33 Global Infectious Disease Diagnostics Market Outlook, By Human Papillomavirus (HPV) (2017-2027) ($MN)
34 Global Infectious Disease Diagnostics Market Outlook, By Influenza (2017-2027) ($MN)
35 Global Infectious Disease Diagnostics Market Outlook, By Methicillin-resistant Staphylococcus Aureus (MRSA) (2017-2027) ($MN)
36 Global Infectious Disease Diagnostics Market Outlook, By Tuberculosis (TB) (2017-2027) ($MN)
37 Global Infectious Disease Diagnostics Market Outlook, By Other Disease Types (2017-2027) ($MN)
38 Global Infectious Disease Diagnostics Market Outlook, By End User (2017-2027) ($MN)
39 Global Infectious Disease Diagnostics Market Outlook, By Academic/Research Institutes (2017-2027) ($MN)
40 Global Infectious Disease Diagnostics Market Outlook, By Ambulatory Surgical Centers (2017-2027) ($MN)
41 Global Infectious Disease Diagnostics Market Outlook, By Blood Banks (2017-2027) ($MN)
42 Global Infectious Disease Diagnostics Market Outlook, By Contract Research Organization (2017-2027) ($MN)
43 Global Infectious Disease Diagnostics Market Outlook, By Diagnostic Clinics (2017-2027) ($MN)
44 Global Infectious Disease Diagnostics Market Outlook, By Home healthcare (2017-2027) ($MN)
45 Global Infectious Disease Diagnostics Market Outlook, By Hospital/Clinical Laboratories (2017-2027) ($MN)
46 Global Infectious Disease Diagnostics Market Outlook, By Nursing Homes (2017-2027) ($MN)
47 Global Infectious Disease Diagnostics Market Outlook, By Physician Offices (2017-2027) ($MN)
48 Global Infectious Disease Diagnostics Market Outlook, By Reference Laboratories (2017-2027) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
Select License Type
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.